Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/3/2005

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

31/03/2005
Quarter1
Financial Year End31/12/2005
The figureshave not been audited

Attachments

pharma_klse0503.doc
657 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/03/2005


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
31/03/2005 
31/03/2004 
31/03/2005 
31/03/2004 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
227,872
191,305
227,872
191,305
2Profit/(loss) before tax
18,249
20,669
18,249
20,699
3Profit/(loss)
after tax and minority
interest
10,699
12,384
10,699
12,384
4Net profit/(loss) for
the period
10,699
12,384
10,699
12,384
5Basic earnings/(loss) per share (sen)
10.48
12.29
10.48
12.29
6Dividend per share (sen)
0.00
0.00
0.00
0.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net tangible assets per share (RM)

2.5200
2.6000

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
The Directors do not recommend any payment of interim dividend for the current period ended 31 March 2005 (2004:Nil).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced18 May 2005  
CategoryFinancial Results
Reference NoCC-050510-64605